Strategies to Prevent Methicillin-ResistantStaphylococcus aureusTransmission and Infection in Acute Care Hospitals: 2014 Update

Methicillin-Resistant Staphylococcus aureus Control in the 21st Century: Laboratory Involvement Affecting Disease Impact and Economic Benefit from Large Population Studies

“…These fines are substantial and will place considerable pressure on U.S. hospitals to reduce or eliminate MRSA nosocomial bacteremia (and eventually all MRSA HAIs). Since AST is one of the core measures for prevention and control in the Society for Health Epidemiologists of America (SHEA) guide for reducing MRSA clinical disease when routine practices are not sufficient (30), this will place increasing pressure on health care organizations to act, and substantial involvement by the clinical microbiology laboratory is very likely.…”

Methicillin-resistant Staphylococcus aureus nasal colonization in a level III neonatal intensive care unit: Incidence and risk factors

“…24 As found by other investigators, in NICUs with a high endemicity and multiple circulating MRSA strains, the objective to definitively eradicate MRSA from the NICU can be unrealistic. 5,25 With a 4-year period of prospective epidemiologic and laboratory surveillance and molecular typing of MRSA isolates, our study provides significant data about risk factors for acquisition and evolution of MRSA clones in a level III NICU. Molecular typing is critical to support effective surveillance and control strategies.…”

A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2014 Updates

“…The major aim of the original documents published in 2008 and the 2014 Compendium updates [15][16][17][18][19][20][21] is to provide acute care hospitals with up-to-date, practical, relatively concise expert guidance to assist in prioritizing and implementing HAI prevention efforts. These articles are the products of a highly collaborative effort led by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), the American Hospital Association (AHA), the Association for Professionals in Infection Control and Epidemiology (APIC), and The Joint Commission, with major contributions from representatives of a number of organizations and societies with content expertise, including the CDC, the Institute for Healthcare Improvement (IHI), the Pediatric Infectious Diseases Society (PIDS), the Society for Critical Care Medicine (SCCM), the Society for Hospital Medicine (SHM), and the Surgical Infection Society (SIS).…”